Linda Yang, MD
Obstetrics & Gynecology · Chicago, ILNPI 1114974557
Payments from drug & device makers
Across 18 payments — averaging $250.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
- Provepharm Inc.$987
- Medical Device Business Services, Inc.$384
- Hologic Sales And Service, LLC$278
- Janssen Scientific Affairs, LLC$117
- AbbVie$106
- plus $179 from 3 others
What the payments were for
- Consulting fees$3,43076%
- Food & beverage$73916%
- Education$3327%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 1 | $2,450 |
| Provepharm Inc. | 2 | $987 |
| Medical Device Business Services, Inc. | 4 | $384 |
| Hologic Sales And Service, LLC | 4 | $278 |
| Janssen Scientific Affairs, LLC | 1 | $117 |
| AbbVie | 2 | $106 |
| Boston Scientific | 1 | $100 |
| Johnson & Johnson | 2 | $56 |
| Medtronic | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$2,450
- BLUDIGO$980
- FLUENT FLUID MANAGEMENT SYSTEM$149
- NovaSure$149
- MYOSURE TISSUE REMOVAL DEVICE$149
- STELARA$117
- GENERAL PELVIC ORGAN PROLAPSE$100
How this compares
$4,501 in reported general payments places this provider in the 85th percentile of 1,732 obstetrics & gynecology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Medroxyprogesterone Acetate | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Chicago
- Lee ShulmanChicago$577K
- Maria TamChicago$378K
- Amy WhitakerChicago$351K
- Gregory UrsinoChicago$242K
- Magdy MiladChicago$211K
- Joseph ThomasChicago$180K
- Ayman Al-HendyChicago$142K
- Nicole TaskerChicago$125K
- Ashlesha PatelChicago$81K
- Teresa HubkaChicago$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.